Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$58M |
| 2 |
Wells Fargo
WFC
|
+$39.8M |
| 3 |
Northrop Grumman
NOC
|
+$39.6M |
| 4 |
Pfizer
PFE
|
+$37.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$33.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$59.8M |
| 2 |
Cigna
CI
|
+$42M |
| 3 |
Altria Group
MO
|
+$28.5M |
| 4 |
Philip Morris
PM
|
+$28.3M |
| 5 |
Parker-Hannifin
PH
|
+$26.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Industrials | 18.96% |
| 3 | Consumer Discretionary | 15.28% |
| 4 | Healthcare | 13.64% |
| 5 | Consumer Staples | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Raymond James Financial
RJF
$33.7B
| $1.99M | 0.03% |
37,164
+30,424
| +451% | +$1.63M |
|
|
CHK
502
DELISTED
Chesapeake Energy Corporation
CHK
| $1.99M | 0.03% |
+3,211
| New | +$1.8M |
|
503
Prologis
PLD
$135B
| $1.96M | 0.03% |
+27,277
| New | +$1.86M |
|
504
Cenovus Energy
CVE
$60.7B
| $1.92M | 0.03% |
220,967
-465,528
| -68% | -$3.86M |
|
505
PPG Industries
PPG
$25.3B
| $1.91M | 0.03% |
16,933
+9,983
| +144% | +$1.07M |
|
|
KEM
506
DELISTED
KEMET Corporation
KEM
| $1.91M | 0.03% |
112,568
-77,646
| -41% | -$1.43M |
|
|
MCRN
507
DELISTED
Milacron Holdings Corp.
MCRN
| $1.91M | 0.03% |
168,549
+75,083
| +80% | +$993K |
|
508
Air Products & Chemicals
APD
$67.9B
| $1.89M | 0.03% |
+9,892
| New | +$1.7M |
|
509
Hilton Worldwide
HLT
$73.5B
| $1.88M | 0.03% |
22,661
-59,607
| -72% | -$4.67M |
|
510
Lincoln National
LNC
$8.07B
| $1.87M | 0.03% |
31,812
+22,501
| +242% | +$1.33M |
|
511
KRONOS Worldwide
KRO
$944M
| $1.86M | 0.03% |
132,896
-45,954
| -26% | -$635K |
|
|
NUVA
512
DELISTED
NuVasive, Inc.
NUVA
| $1.85M | 0.03% |
32,545
+28,435
| +692% | +$1.51M |
|
513
Louisiana-Pacific
LPX
$5.12B
| $1.8M | 0.03% |
73,901
+15,310
| +26% | +$374K |
|
514
Insight Enterprises
NSIT
$4.33B
| $1.79M | 0.03% |
32,502
-43,061
| -57% | -$2.17M |
|
|
SWN
515
DELISTED
Southwestern Energy Company
SWN
| $1.78M | 0.03% |
+380,453
| New | +$1.64M |
|
516
Enanta Pharmaceuticals
ENTA
$392M
| $1.78M | 0.03% |
18,652
-3,830
| -17% | -$344K |
|
|
HZNP
517
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.78M | 0.03% |
+67,318
| New | +$1.6M |
|
518
Aflac
AFL
$58.2B
| $1.77M | 0.03% |
35,411
-4,785
| -12% | -$231K |
|
519
Bath & Body Works
BBWI
$3.92B
| $1.77M | 0.03% |
+79,414
| New | +$1.75M |
|
520
CGI
GIB
$15.5B
| $1.76M | 0.03% |
25,618
-49,674
| -66% | -$3.28M |
|
|
TMX
521
DELISTED
Terminix Global Holdings, Inc.
TMX
| $1.74M | 0.03% |
37,228
-115,154
| -76% | -$4.81M |
|
522
Keysight
KEYS
$53.8B
| $1.72M | 0.03% |
19,732
-42,953
| -69% | -$3.33M |
|
|
TECD
523
DELISTED
Tech Data Corp
TECD
| $1.72M | 0.03% |
16,754
-4,712
| -22% | -$461K |
|
524
Waters Corp
WAT
$40.4B
| $1.71M | 0.03% |
6,778
-5,135
| -43% | -$1.17M |
|
525
Neurocrine Biosciences
NBIX
$15.5B
| $1.7M | 0.02% |
19,332
+2,956
| +18% | +$247K |
|
Similar funds
Joel Greenblatt's Q1 2019 Portfolio in Review
As of Q1 2019, Joel Greenblatt held 1,284 positions worth $6.83B, up 6.1% from $6.44B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $437M in Q1 2019, closing 124 positions and reducing 485 holdings. Its most notable exit was Cigna, an estimated $42M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Joel Greenblatt opened a new position in General Dynamics worth $58.2M.
- Joel Greenblatt's largest Q1 2019 buy was General Dynamics: 343,980 shares worth $58.2M.
- Joel Greenblatt added most to Wells Fargo in Q1 2019, an estimated $39.8M increase.
- Joel Greenblatt's biggest Q1 2019 reduction was RTX Corp, cutting an estimated $59.8M.
- Joel Greenblatt fully exited Cigna in Q1 2019, selling an estimated $42M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.83B portfolio in Q1 2019.
- Joel Greenblatt opened 319 new positions and closed 124 in Q1 2019.
- Joel Greenblatt's portfolio value rose 6.1% quarter-over-quarter to $6.83B.
Based on Gotham Asset Management's 13F filing for Q1 2019, filed 15 May 2019.